TIAA CREF Investment Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$10.5M Buy
420,079
+106,333
+34% +$2.03M 0.01% 1016
2018
Q4
$3.95M Buy
313,746
+119,497
+62% +$1.41M ﹤0.01% 1529
2018
Q3
$1.85M Buy
194,249
+71,510
+58% +$789K ﹤0.01% 2157
2018
Q2
$1.15M Buy
122,739
+1,162
+1% +$8.17K ﹤0.01% 2437
2018
Q1
$676K Buy
121,577
+18,617
+18% +$115K ﹤0.01% 2620
2017
Q4
$672K Sell
102,960
-1,813
-2% -$13.5K ﹤0.01% 2649
2017
Q3
$919K Buy
104,773
+11,415
+12% +$92.8K ﹤0.01% 2561
2017
Q2
$778K Buy
93,358
+29,406
+46% +$240K ﹤0.01% 2666
2017
Q1
$587K Buy
63,952
+14,852
+30% +$122K ﹤0.01% 2742
2016
Q4
$380K Buy
49,100
+3,303
+7% +$24.7K ﹤0.01% 2925
2016
Q3
$349 Hold
45,797
﹤0.01% 2967
2016
Q2
$230K Buy
45,797
+13,468
+42% +$72.2K ﹤0.01% 3074
2016
Q1
$175K Hold
32,329
﹤0.01% 2999
2015
Q4
$233K Hold
32,329
﹤0.01% 3050
2015
Q3
$152K Hold
32,329
﹤0.01% 3057
2015
Q2
$360K Buy
32,329
+10,014
+45% +$98.6K ﹤0.01% 3040
2015
Q1
$162K Hold
22,315
﹤0.01% 3073
2014
Q4
$216K Sell
22,315
-3,172
-12% -$24.8K ﹤0.01% 3089
2014
Q3
$248K Buy
25,487
+700
+3% +$9.19K ﹤0.01% 3074
2014
Q2
$424K Buy
24,787
+12,340
+99% +$178K ﹤0.01% 3037
2014
Q1
$213K Hold
12,447
﹤0.01% 3071
2013
Q4
$180K Buy
+12,447
New +$162K ﹤0.01% 3090

Other funds holding VCYT

TIAA CREF Investment Management's VCYT Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Veracyte (VCYT) stake by 34% in Q1 2019, buying an estimated $2.03M and bringing the position to 420,079 shares worth $10.5M. The position accounts for 0.01% of the portfolio, ranked #1016.

TIAA CREF Investment Management first reported a position in VCYT in Q4 2013 and has held it in 22 quarters since. 149 funds tracked by Wall St. Rank hold VCYT as of Q1 2019.

  • TIAA CREF Investment Management held 420,079 shares of Veracyte worth $10.5M as of Q1 2019.
  • TIAA CREF Investment Management bought 106,333 Veracyte shares in Q1 2019, an estimated $2.03M.
  • Veracyte made up 0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1016 holding.
  • TIAA CREF Investment Management first reported a position in Veracyte in Q4 2013 and has held it in 22 quarters since.
  • 149 funds tracked by Wall St. Rank held Veracyte as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.